AAAAAA

   
Results: 1-4 |
Results: 4
ACETYL-L-CARNITINE DEFICIENCY AS A CAUSE OF ALTERED NERVE MYOINOSITOLCONTENT, NA,K-ATPASE ACTIVITY, AND MOTOR CONDUCTION-VELOCITY IN THE STREPTOZOTOCIN-DIABETIC RAT
Authors: STEVENS MJ LATTIMER SA FELDMAN EL HELTON ED MILLINGTON DS SIMA AAF GREENE DA
Citation: Mj. Stevens et al., ACETYL-L-CARNITINE DEFICIENCY AS A CAUSE OF ALTERED NERVE MYOINOSITOLCONTENT, NA,K-ATPASE ACTIVITY, AND MOTOR CONDUCTION-VELOCITY IN THE STREPTOZOTOCIN-DIABETIC RAT, Metabolism, clinical and experimental, 45(7), 1996, pp. 865-872
MULTIPLE-DOSE PHARMACOKINETICS AND BIOEQUIVALENCE OF L-CARNITINE 330-MG TABLET VERSUS 1-G CHEWABLE TABLET VERSUS ENTERAL SOLUTION IN HEALTHY ADULT MALE-VOLUNTEERS
Authors: SAHAJWALLA CG HELTON ED PURICH ED HOPPEL CL CABANA BE
Citation: Cg. Sahajwalla et al., MULTIPLE-DOSE PHARMACOKINETICS AND BIOEQUIVALENCE OF L-CARNITINE 330-MG TABLET VERSUS 1-G CHEWABLE TABLET VERSUS ENTERAL SOLUTION IN HEALTHY ADULT MALE-VOLUNTEERS, Journal of pharmaceutical sciences, 84(5), 1995, pp. 627-633
COMPARISON OF L-CARNITINE PHARMACOKINETICS WITH AND WITHOUT BASE-LINECORRECTION FOLLOWING ADMINISTRATION OF SINGLE 20-MG KG INTRAVENOUS DOSE/
Authors: SAHAJWALLA CG HELTON ED PURICH ED HOPPEL CL CABANA BE
Citation: Cg. Sahajwalla et al., COMPARISON OF L-CARNITINE PHARMACOKINETICS WITH AND WITHOUT BASE-LINECORRECTION FOLLOWING ADMINISTRATION OF SINGLE 20-MG KG INTRAVENOUS DOSE/, Journal of pharmaceutical sciences, 84(5), 1995, pp. 634-639
MAXIMUM DOSAGE LEVEL IN TESTING LOW-TOXICITY CHEMICALS FOR CARCINOGENICITY IN RODENTS
Authors: APOSTOLOU A HELTON ED
Citation: A. Apostolou et Ed. Helton, MAXIMUM DOSAGE LEVEL IN TESTING LOW-TOXICITY CHEMICALS FOR CARCINOGENICITY IN RODENTS, Journal of applied toxicology, 13(3), 1993, pp. 209-212
Risultati: 1-4 |